Related Experiment Video
Updated: Sep 26, 2025

Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels
Published on: August 7, 2017
Comparisons of Clinical Features and Outcomes of COVID-19 between Patients with Pediatric Onset Inflammatory
Fatih Haslak1, Sevki Erdem Varol1, Aybuke Gunalp1
1Department of Pediatric Rheumatology, Cerrahpasa Medical School, Istanbul University-Cerrahpasa, Istanbul 34303, Turkey.
Insights
Children with inflammatory rheumatic diseases (IRD) face higher risks of symptomatic COVID-19 and hospitalization compared to healthy children. Pediatric rheumatologists must closely monitor these patients for potentially worse outcomes.
Area of Science:
- Pediatric Rheumatology
- Infectious Diseases
- Clinical Outcomes
Background:
- Investigating coronavirus disease-2019 (COVID-19) clinical features and outcomes in pediatric patients with inflammatory rheumatic diseases (IRD).
- Comparing COVID-19 severity risks in IRD children versus healthy children.
Purpose of the Study:
- To describe clinical features and outcomes of COVID-19 in children and late adolescents with IRD.
- To assess the risk of severe COVID-19 in IRD patients compared to healthy controls.
Main Methods:
- Retrospective study including 658 polymerase chain reaction (PCR)-confirmed SARS-CoV-2 positive subjects (152 IRD patients, 506 healthy children).
- Inclusion criteria required at least a six-month follow-up duration for IRD patients.
Main Results:
- Of 658 subjects, 86.6% experienced COVID-19 symptoms; only 3.19% required hospitalization.
- Inflammatory rheumatic diseases (IRD) significantly increased the risk of hospitalization (OR: 5.205) and symptomatic infection (OR: 2.579).
- Increasing age was associated with symptomatic infection (OR: 1.051); no deaths or significant sequelae were reported.
Conclusions:
- Children with IRD have a substantially higher risk of severe COVID-19 outcomes, including hospitalization.
- Pediatric rheumatologists should maintain close surveillance of IRD patients for COVID-19 management.
- Early identification and monitoring are crucial for mitigating adverse COVID-19 effects in pediatric rheumatology patients.
Abstract:
(1) Background: We aimed to describe the clinical features and outcomes of coronavirus disease-2019 (COVID-19) in children and late adolescents with inflammatory rheumatic diseases (IRD) and to measure their severity risks by comparing them with healthy children. (2) Methods: Among children and late adolescents found to be severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) positive via polymerase chain reaction (PCR) test, IRD patients with an at least six-months follow-up duration, and healthy children were included in the study. Data were obtained retrospectively. (3) Results: A total of 658 (339 (51.5%) females) (healthy children: 506, IRD patients: 152) subjects were included in the study. While 570 of 658 (86.6%) experienced COVID-19-related symptoms, only 21 (3.19%) required hospitalization with a median duration of 5 (1-30) days. Fever, dry cough, and fatigue were the most common symptoms. None of evaluated subjects died, and all recovered without any significant sequelae. The presence of any IRD was found to increase the risk of both hospitalization (OR: 5.205; 95% CI: 2.003-13.524) and symptomatic infection (OR: 2.579; 95% CI: 1.068-6.228). Furthermore, increasing age was significantly associated with symptomatic infection (OR: 1.051; 95% CI: 1.009-1.095). (4) Conclusions: Our study emphasizes that pediatric rheumatologists should monitor their patients closely for relatively poor COVID-19 outcomes.
More Related Videos
08:44Separation of Immune Cell Subpopulations in Peripheral Blood Samples from Children with Infectious Mononucleosis
Published on: September 7, 2022
09:01An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
Published on: December 10, 2013
Related Concept Videos
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Myocarditis II: Clinical Features and Diagnostic Tests
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Rheumatic Heart Disease I: Introduction
Pericarditis II: Clinical Features and Diagnostic Tests
Endocarditis II: Clinical Features of Infective Endocarditis